Sufferers who acquired oxymorphone ER in the double-blind period exhibited consistent statistically sizeable improvement in VAS-rated discomfort depth relative to placebo-treated clients ( The conversion ratio of methadone to other opioid agonists may well fluctuate broadly as being a purpose of previous exposure, simply because methadone has a